Business Wire

ADTRAN

27.2.2024 14:01:49 CET | Business Wire | Press release

Share
Telstra trials Adtran FSP 150 for edge compute services

Adtran today announced that Telstra has successfully trialed its FSP 150 edge compute device, opening the door to enhanced network services for business customers across Australia. By incorporating Red Hat’s OpenShift software directly onto Adtran’s hosting platform, Telstra succeeded in facilitating the efficient management and operation of small applications right at the device edge. The solution will enable multiple applications to run on a single device, reducing the need for additional hardware investments. This approach will empower businesses to derive new value from their existing hardware, leading to a reduction in inventory sprawl and power usage, and making operations more environmentally friendly. The collaboration shows the potential for Telstra customers to benefit from operational efficiency gains while also delivering enhanced control over network security and data usage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240227823763/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Telstra is using Adtran’s FSP 150 to show how businesses can unlock more value from their networks with edge compute devices. (Photo: Business Wire)

“This initiative pushes the boundaries of how device edge capabilities will enhance the way businesses operate, helping them do more with less and generate more value from existing hardware,” said Channa Seneviratne, technology development and innovation executive at Telstra. “Alongside simplification, this trial demonstrates how we can enable a more distributed and intelligent network with better resiliency, performance and workload distribution. It’s another step forward in our ambition to unlock more value for customers and continue to drive technology leadership.”

Telstra’s successful trial of Red Hat’s Linux-based OS and OpenShift Container Platform on Adtran FSP 150 devices makes it possible to leverage new capabilities from hardware already sitting in customers’ networks. This approach boosts value, reduces additional investment needs and enhances operational efficiency. Hosting applications at the network edge also brings about stronger security, better data management and improved network reliability, all while streamlining the deployment and management of applications. What’s more, the strategy promotes innovation and equips businesses to adapt to future technological changes and market demands. The edge hosting device utilized in the trial was the FSP 150-XG304u, which is powered by a robust Intel Xeon D processor. Offering substantial bandwidth and processing power, it’s ideal for hosting multiple revenue-generating applications at the edge.

“Together with Telstra and Red Hat, we’re helping transform traditional edge hardware into versatile devices capable of running multiple applications. By enabling operators like Telstra to host VNFs directly at the network edge, we’re optimizing response times and reducing the need for extensive backhaul bandwidth, leading to significant energy and opex savings. Bringing cloud capabilities to the edge also eliminates the need for additional network elements and extra space at the customer premises, ensuring a more streamlined and cost-efficient infrastructure,” commented Anthony Camilleri, APAC CTO at Adtran. “Our FSP 150 Series merges top-tier Carrier Ethernet functionality with the flexibility of open hosting for edge cloud applications. This empowers operators to provide reliable business-class data services alongside innovative end-user services, all within a single carrier-class device.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by
ADTRAN Holdings, Inc.
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227823763/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye